Sage, a major independent academic publisher, has announced the acquisition of Mary Ann Liebert, Inc., a well-known global media firm with a rich history of biotechnology, life sciences, and specialized medical publishing.  Sage's portfolio will now include over 100 peer-reviewed publications, including significant titles in public health, policy, and medical technology. This transaction also includes significant B2B media brands, including Genetic Engineering & Biotechnology News (GEN) and Inside Precision Medicine.

Sage's CEO, Blaise Simqu, emphasized the acquisition's historical significance, citing Mary Ann Liebert and its founder, Sara Miller McCune, as pioneers in defining the publishing environment.  "Both women took bold risks, created vital academic platforms, and helped foster research that serves humanity," she said. He noted that the acquisition would allow Mary Ann Liebert, Inc. to continue to thrive under Sage's independent and entrepreneurial leadership.

As part of the transaction, Sage will publish a selection of life sciences and medical journals under the Liebert banner, while Mary Ann Liebert, Inc. will continue to publish journals under its name. This collaboration seeks to expand the reach and impact of Mary Ann Liebert's influential publications.

Since its founding in 1980, Mary Ann Liebert, Inc. has pioneered publishing in new fields such as genetic engineering, tissue engineering, and patient care. Among its innovative titles are Genetic Engineering & Biotechnology News (GEN), a significant media brand in biotechnology today, and AIDS Research & Human Retroviruses, established during the AIDS pandemic. More recently, the business has published journals like AI in Precision Oncology and AI in Neuroscience.

Marianne Russell, CEO of Mary Ann Liebert, Inc., stated her excitement about the acquisition, citing Sage's fit with their objective of advancing scientific and medical research. "This acquisition will amplify our reach and impact, ensuring the continuation of our commitment to quality content that benefits the global research community," Russell told me.

Sage intends to honor Mary Ann Liebert, Inc.'s legacy by expanding the reach of its top-ranked journals, such as Diabetes Technology & Therapeutics and Advances in Wound Care.  The acquisition is projected to enhance the publishing landscape for both instructional multimedia content (webinars, podcasts, and eBooks) and academic research.

According to Bob Howard, Sage's Executive Vice President of Research, "The quality of Mary Ann Liebert, Inc.'s journals is exceptional, and we're excited to build upon that foundation while expanding the reach of this influential portfolio."

The merging process will begin immediately, with an emphasis on retaining both firms' reputations for excellent publishing quality and customer service. Authors, editors, and readers may expect a smooth transition and continuing access to current Mary Ann Liebert, Inc. journals.